CQ7562
Bard Conquest PTA Balloon Dilatation Catheter 6mm x 20mm, 75cm
$49.00
box of 1
In Stock: 2 Eaches
Expiration:
Expired
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Medtronic Monosof black 30" SC-2 cutting
$2.55 packets
Medtronic Monosof black 12" SE-CC-6 spatula, double armed
$12.00 box of 12
Medtronic Biosyn undyed 18" P-13 Reverse Cutting Needle
$10.00 packets
Medtronic Biosyn undyed 30" GS-22 taper
$3.40 packets
Medtronic Monosof black 8" SE-CC-6 spatula, double armed
$30.00 packets
Medtronic Biosyn undyed 30" C-14 (FS-1) Reverse Cutting
$2.00 packets
Additional information
| Size | 6.00mm |
|---|---|
| Arms | N/A |
| Balloon Length | 20mm |
| Manufacturer | |
| Type | Balloons |
| Unit | box of 1 |
| Usable Length | 75cm |
- FDA Product Code: DQY
- FDA Product Code Name: CATHETER, PERCUTANEOUS
- GMDN Term Code: 17184
- GMDN Term Name: Peripheral angioplasty balloon catheter, basic
- GMDN Term Description: A sterile, non-drug-eluting, flexible tube designed for percutaneous transluminal angioplasty (PTA) to dilate a stenotic peripheral (i.e., non-cerebral, non-coronary) artery by controlled inflation of a distensible balloon(s) at its distal tip; it may also be intended for positioning and expansion of a stent/stent-graft. It is available as an over-the-wire (OTW) type with multiple lumens, or a rapid exchange (RX) type with a single lumen. Some types may include cutting/scoring elements (e.g., microsurgical blades, dual wire configurations) to score/modify the plaque. This is a single-use device.
Bard PV
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.